Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Diagnostics (Basel, Switzerland)|June 24, 2022
Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after VaccinationNuchjira Takheaw, Chalerm Liwsrisakun, Warawut Chaiwong, et al.
Journal of Clinical Medicine|April 12, 2025
Biomarkers of Oxidative Stress, Systemic Inflammation and Thrombosis in Adult Asthmatic Patients Treated with Inhaled Corticosteroids During Exposure to Fine Particulate MatterWarawut Chaiwong, Chalerm Liwsrisakun, Juthamas Inchai, et al.
Immunity & Ageing : I & A|May 24, 2022
Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccineChalerm Liwsrisakun, Supansa Pata, Witida Laopajon, et al.
Heliyon|April 25, 2023
Levels and durability of neutralizing antibodies against SARS-CoV-2 Omicron and other variants after ChAdOx-1 or BNT162b2 booster in CoronaVac-primed elderly individualsNuchjira Takheaw, Chalerm Liwsrisakun, Witida Laopajon, et al.
International Journal of Molecular Sciences|July 28, 2026
Effects of Fine Particulate Matter on Systemic Inflammatory Biomarkers in Elderly Patients with Chronic Obstructive Pulmonary Disease Versus the Healthy Elderly: A Pilot StudyWarawut Chaiwong, Chalerm Liwsrisakun, Pilaiporn Duangjit, et al.
Vaccine|June 5, 2025
Low-dose intradermal mRNA-1273 boosting vaccine following BBiBP-CorV vaccination during the omicron pandemicsWarawut Chaiwong, Nuchjira Takheaw, Witida Laopajon, et al.
Vaccines|December 23, 2022
Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary StudyWarawut Chaiwong, Nuchjira Takheaw, Witida Laopajon, et al.
Infection & Chemotherapy|May 9, 2025
Immune Responses Against SARS-CoV-2 in Previously SARS-CoV-2-Infected Individuals after Receiving a Single Dose of CoronaVac or ChAdOx-1 VaccineWitida Laopajon, Athavudh Deesomchok, Warawut Chaiwong, et al.
Asian Pacific Journal of Allergy and Immunology|February 11, 2023
Humoral and cellular immune responses against SARS-CoV-2 variants of concern induced by heterologous CoronaVac/ChAdOx-1 versus homologous ChAdOx-1 vaccination in the elderlyChalerm Liwsrisakun, Supansa Pata, Witida Laopajon, et al.
Vaccine|August 20, 2023
Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary diseaseWarawut Chaiwong, Nuchjira Takheaw, Supansa Pata, et al.
Pageof 7